Thanks sabine. I like the $10B USD TAM number (total addressable market)...
I'm trying to search for typical buyout premiums for biotechs such as OPT. Even at 1x multiple of TAM....the optimistic valuation would be 18x current valuation. Big numbers.... I may be dreaming/too optimistic. Goldmann's number seems low to me, but what do I know.
Ann: Opthea Raises A$50 million in Institutional Placement, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.5¢ |
Change
0.030(5.41%) |
Mkt cap ! $720.1M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 58.5¢ | 54.0¢ | $1.386M | 2.445M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34043 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 33845 | 3 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |